Shares of Cronos Group were rising Tuesday after the cannabis company posted a solid first-quarter earnings report. Cronos (ticker: CRON ) doubled its net revenue year over year, raking in $25 million during the first quarter and beating analysts’ estimates for $24 million in revenue. The increase was primarily driven by an increase in international markets, especially the growth of the Israeli medical market and Canadian adult-use market, the company said in a press release. Read More...
Shares of Cronos Group were rising Tuesday after the cannabis company posted a solid first-quarter earnings report. Cronos (ticker: CRON ) doubled its net revenue year over year, raking in $25 million during the first quarter and beating analysts’ estimates for $24 million in revenue. The increase was primarily driven by an increase in international markets, especially the growth of the Israeli medical market and Canadian adult-use market, the company said in a press release.
